Photo taken from: Gustavo / Twitter
Jul 27, 2023, 06:55
A durable antitumor activity to atezolizumab was observed in a subset of penile cancer – Gustavo
Although failed to achieve, a durable antitumor activity to atezolizumab was observed in a subset of penile cancer.
Single-center, PhII study 32 treated w/ atezolizumab; 20 received additional RT: 1-y PFS (goal 35%)
RESULTs:
Median FU 29 m
Median OS was 11.3 m
1-yPFS 12.5 %
ORR 16.7% w/ 2 complete and 3 partial responders
PFS in hrHPV + tumors & high T cell infiltration
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12